Tag archief: English Only

Finsbury Glover Hering and Sard Verbinnen & Co. Complete Merger, Creating Global Strategic Communications Leader

NEW YORK–(BUSINESS WIRE)– Following their announcement on October 13, 2021, Finsbury Glover Hering and Sard Verbinnen & Co. (“SVC”) have completed their merger to create...

Amazon Investing in 274 Renewable Energy Projects Globally, Adds 18 New Projects in Europe and U.S.

Amazon is the largest corporate buyer of renewable energy globally and is on a path to power 100% of its business with renewable energy by...

Calastone Announces Strategic Partnership With Microsoft to Accelerate the Digital Transformation of Funds and Collective Investments

Calastone and Microsoft share vision for digitally enabled collective investments and funds Calastone introduced its innovative DMI Fund Services solution leveraging Distributed Ledger Technology (DLT)...

CHG Healthcare Switches to Rimini Street to Achieve Better System Availability, Smoother Operation and Enhanced Outcomes for 25 Million Patients Annually

Largest private healthcare staffing firm receives ultra-responsive, high-quality JD Edwards support for its provider and client systems to ensure patients have access to necessary care...

Bullish Goes Live With Institutional Customers After Obtaining Regulatory License in Gibraltar

GIBRALTAR–(BUSINESS WIRE)– Bullish, a blockchain-based cryptocurrency exchange, today announced the initial launch of its platform to select institutional customers, following the receipt of a distributed...

Samsung Introduces Three New Logic Solutions to Power the Next Generation of Automobiles

Samsung adds 5G connectivity with the Exynos Auto T5123, performance with the Exynos Auto V7 and reliability with the ASIL-B certified power management IC for...

VicTrack wins Aussie Broadband wholesale deal with ADVA FSP 3000

News summary: State-wide infrastructure built on ADVA’s open optical transport technology enables robust and flexible wholesale services VicTrack’s unique footprint and ADVA’s solution give Aussie...

Vifor Pharma announces changes to the Executive Committee as CFO retires

Colin Bond to retire as Chief Financial Officer of Vifor Pharma Group Succession recruitment ongoing ST. GALLEN, Switzerland–(BUSINESS WIRE)– Regulatory News: AD HOC ANNOUNCEMENT PURSUANT...

Celltrion accelerates development of nebulised cocktail therapy (CT-P63 in combination with CT-P59) using its antibody platform to tackle new COVID-19 variants

Celltrion previously completed phase I clinical trials with a nebulised formulation of Regkirona (regdanvimab, CT-P59), a monoclonal antibody treatment for COVID-19 Celltrion anticipates CT-P63 to...

Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients

ALASTIN Skincare® was the fastest growing brand in the U.S. professional skincare market in 20201 ALASTIN’s patented, differentiated technology and products are highly synergistic with...

Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis

Iron Deficiency Day unites a strong international coalition dedicated to raising international awareness on the serious health impact of iron deficiency and iron deficiency anemia1...

Alter Domus Strengthens its Competitive Differentiation with Continued Investments in European Operational Excellence

€50 million capital investment includes the expansion of core operations in Ireland, the 2021 launch of operations in Lithuania and an ambitious digital agenda to...

FCC Validates SES Phase I Accelerated C-band Clearing and Relocation Certification

FCC validation ahead of the 5 December 2021 Phase I accelerated relocation deadline secures the first accelerated relocation payment of $1bn to SES LUXEMBOURG–(BUSINESS WIRE)–...

ADVA’s management board and supervisory board recommend shareholders tender their shares into ADTRAN offer

MUNICH–(BUSINESS WIRE)– ADVA (FSE:ADV) today announced that its management board and supervisory board have issued a joint reasoned statement pursuant to Section 27 of the...

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies

– In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV infection/disease achieved confirmed...